BSECompany Update23 Jun 2026 · 23 Jun 2026, 06:17 pm
Approval for acquisition of Fluence Pharma Private Limited and incorporation of a wholly owned subsidiary
Honasa Consumer Ltd · 544014
✦ AI Summary▲ PositiveM&A
Honasa Consumer Ltd announced the acquisition of a 58% equity stake in Fluence Pharma Private Limited, a company offering condition-specific OTC supplements under brands like "Hair Fact, Skin Fact, and Pro Fact." The acquisition, valued at approximately ₹135 Crores enterprise value for the initial stake, strategically marks Honasa's entry into the high-growth nutraceuticals market, with plans to acquire the remaining 42% over the next 5-7 years. Additionally, Honasa will incorporate a wholly-owned subsidiary, 'Honasa Health Private Limited,' to manage its new B2C nutraceuticals operations.
Analysis Scores
Earnings Impact7/10
Growth Catalyst9/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk3/10
Liquidity Impact5/10
Market Sentiment8/10
Full Announcement
Honasa Consumer Ltd - 544014 - Announcement under Regulation 30 (LODR)-Acquisition